These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Jensen LS Lancet; 1994 Nov; 344(8934):1429; author reply 1430-1. PubMed ID: 7848458 [No Abstract] [Full Text] [Related]
3. Blood transfusion-induced immunomodulation. Landers DF; Hill GE; Wong KC; Fox IJ Anesth Analg; 1996 Jan; 82(1):187-204. PubMed ID: 8712400 [No Abstract] [Full Text] [Related]
4. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM). Vamvakas EC Crit Care Med; 2006 May; 34(5 Suppl):S151-9. PubMed ID: 16617260 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Bordin JO; Blajchman MA Hematol Oncol Clin North Am; 1995 Feb; 9(1):205-18. PubMed ID: 7737942 [TBL] [Abstract][Full Text] [Related]
6. [Immunosuppression induced by homologous blood transfusion]. Fariñas Guerrero F; Muñoz Gómez M; García Vallejo JJ; Ruiz Romero de la Cruz MD; Morell Ocaña M Sangre (Barc); 1998 Jun; 43(3):213-7. PubMed ID: 9741228 [No Abstract] [Full Text] [Related]
8. Transfusion immunomodulation from a clinical perspective: an update. Refaai MA; Blumberg N Expert Rev Hematol; 2013 Dec; 6(6):653-63. PubMed ID: 24168641 [TBL] [Abstract][Full Text] [Related]
9. Relationship of blood transfusion, post-operative infections and immunoreactivity in patients undergoing surgery for gastrointestinal cancer. Quintiliani L; Pescini A; Di Girolamo M; Iudicone P; Martini F; Guglielmetti M; Buzzonetti A; Fascioli S Haematologica; 1997; 82(3):318-23. PubMed ID: 9234579 [TBL] [Abstract][Full Text] [Related]
10. Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Blumberg N; Heal JM Yale J Biol Med; 1990; 63(5):429-33. PubMed ID: 2293502 [TBL] [Abstract][Full Text] [Related]
11. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Heiss MM; Mempel W; Jauch KW; Schildberg FW Lancet; 1994 Nov; 344(8934):1429-30; author reply 1430-1. PubMed ID: 7968084 [No Abstract] [Full Text] [Related]
12. [Clinical consequences TRIM (Transfusion related immunomodulation)]. Průcha M Vnitr Lek; 2006 Nov; 52(11):1012-3. PubMed ID: 17165518 [No Abstract] [Full Text] [Related]
14. Transfusion-related immunologic abnormalities in beta-thalassemia major. Grady RW; Akbar AN; de Sousa M; Giardina PJ; Hilgartner MW Birth Defects Orig Artic Ser; 1987; 23(5A):587-93. PubMed ID: 3689945 [No Abstract] [Full Text] [Related]
15. Blood transfusion-induced immunomodulation--is storage time important? Mynster T Dan Med Bull; 2003 Nov; 50(4):368-84. PubMed ID: 14694852 [No Abstract] [Full Text] [Related]
16. [Analysis of the cost effectiveness ratio of an autotransfusion program for primary prosthetic knee and hip surgery]. Muñoz Gómez M; García-Vallejo JJ; Clavero Barranquero A; López-Andrade Jurado A; Ruiz Romero de la Cruz MD Rev Esp Anestesiol Reanim; 2001 Jan; 48(1):43-4. PubMed ID: 11234608 [No Abstract] [Full Text] [Related]
17. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Blajchman MA; Dzik S; Vamvakas EC; Sweeney J; Snyder EL Transfus Med Rev; 2001 Apr; 15(2):108-35. PubMed ID: 11309732 [No Abstract] [Full Text] [Related]
18. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Jensen LS; Kissmeyer-Nielsen P; Wolff B; Qvist N Lancet; 1996 Sep; 348(9031):841-5. PubMed ID: 8826808 [TBL] [Abstract][Full Text] [Related]
19. What has universal leucodepletion given us: evidence from clinical trials? van de Watering L Vox Sang; 2004 Jul; 87 Suppl 2():139-42. PubMed ID: 15209899 [No Abstract] [Full Text] [Related]